SCHEMBL8875855

SCHEMBL8875855

CNCc1cccc2c(=O)c(C)c(-c3ccccc3)oc12

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 6/20 0.48
MAPT P10636 5/20 0.48
SMN1; SMN2 Q16637 4/20 0.48
NPSR1 Q6W5P4 3/20 0.48
GAA P10253 1/20 0.48
ALDH1A1 P00352 7/20 0.47
CYP3A4 P08684 2/20 0.45
HTR1A P08908 2/20 0.45
ADRA1A P35348 2/20 0.45
KDM4E B2RXH2 1/20 0.45
CYP1A2 P05177 1/20 0.45
CHRM2 P08172 1/20 0.45
ADRA2A P08913 1/20 0.45
ADORA3 P0DMS8 1/20 0.45
CYP2D6 P10635 1/20 0.45
CHRM1 P11229 1/20 0.45
ACHE P22303 1/20 0.45
SLC6A2 P23975 1/20 0.45
PDE4A P27815 1/20 0.45
OPRM1 P35372 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14266220 0.86 LMNA (0.55) LMNAMAPTSMN1; SMN2NPSR1GAA
SCHEMBL5118184 0.85 LMNA (0.54) LMNAMAPTSMN1; SMN2NPSR1GAA
SCHEMBL8875991 0.84 LMNA (0.47) LMNAMAPTSMN1; SMN2NPSR1GAA
SCHEMBL5116298 0.84 LMNA (0.50) LMNAMAPTSMN1; SMN2NPSR1GAA
SCHEMBL8874632 0.84 LMNA (0.50) LMNAMAPTSMN1; SMN2NPSR1GAA
SCHEMBL8875205 0.82 ALDH1A1 (0.49) LMNAMAPTSMN1; SMN2NPSR1GAA
SCHEMBL8875368 0.82 GLA (0.63) LMNAMAPTSMN1; SMN2NPSR1GAA
SCHEMBL8876518 0.81 MAPT (0.49) LMNAMAPTSMN1; SMN2NPSR1GAA
SCHEMBL8876597 0.81 LMNA (0.42) LMNAMAPTSMN1; SMN2NPSR1GAA
SCHEMBL8876534 0.81 AURKA (0.49) LMNAMAPTSMN1; SMN2NPSR1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1040434-C Heterobicyclic compounds RECORDATI CHEM PHARM (CH) 1998-10-28 CN disclosed
US-5605896-A Bicyclic heterocyclic derivatives having α1 adrenergic and 5HT1A activities RECORDATI S.A., CHEMICAL AND PHARMACEUTICAL COMPANY (CH) 1997-02-25 US disclosed
US-5474994-A Treating hypertension, urethral and lower urinary tract contractions RECORDATI S.A., CHEMICAL AND PHARMACEUTICAL COMPANY (CH) 1995-12-12 US disclosed
US-5453518-A Antispasmodic agents, treatment of urinary incontinence RECORDATI S.A., CHEMICAL AND PHARMACEUTICAL COMPANY (CH) 1995-09-26 US disclosed
EP-0566288-B1 Flavone derivatives RECORDATI CHEM PHARM (CH) 1995-08-02 EP disclosed
US-5403842-A Adrenergic blocking and antiserotonine agents; urogenital disorders including spasms of the urethral tract and prostrate problems RECORDATI S.A., CHEMICAL AND PHARMACEUTICAL COMPANY (CH) 1995-04-04 US disclosed
CN-1079738-A Heterobicyclic compounds RECORDATI CHEM PHARM (CH) 1993-12-22 CN disclosed
WO-1993017007-A1 HETEROBICYCLIC COMPOUNDS RECORDATI INDUSTRIA CHIMICA E FARMACEUTICA S.P.A. (IT) 1993-09-02 WO disclosed
EP-0558245-A1 Heterobicyclic compounds as antagogists of alpha-1 adrenergic and SHT1A receptors RECORDATI S.A. CHEMICAL and PHARMACEUTICAL COMPANY (CH) 1993-09-01 EP disclosed